Literature DB >> 21057386

Direct application of the tumor necrosis factor-α inhibitor, etanercept, into a punctured intervertebral disc decreases calcitonin gene-related peptide expression in rat dorsal root ganglion neurons.

Manato Horii1, Sumihisa Orita, Maiko Nagata, Masashi Takaso, Kazuyo Yamauchi, Masaomi Yamashita, Gen Inoue, Yawara Eguchi, Nobuyasu Ochiai, Shunji Kishida, Yasuchika Aoki, Tetsuhiro Ishikawa, Gen Arai, Masayuki Miyagi, Hiroto Kamoda, Kazuki Kuniyoshi, Miyako Suzuki, Junichi Nakamura, Tomoaki Toyone, Kazuhisa Takahashi, Seiji Ohtori.   

Abstract

STUDY
DESIGN: retrograde neurotracing and immunohistochemistry were used to investigate the effect of the tumor necrosis factor (TNF)-α inhibitor, etanercept, on calcitonin gene-related peptide (CGRP) expression in dorsal root ganglion (DRG) neurons innervating intervertebral discs in rats.
OBJECTIVE: to clarify the action of a TNF-α inhibitor on a sensory neuropeptide in DRG neurons innervating intervertebral discs. SUMMARY OF BACKGROUND DATA: degeneration of lumbar intervertebral discs is a cause of low back pain. TNF-α in the intervertebral disc is a major contributor to discogenie pain. Effects of TNF-α inhibition on CGRP expression in DRG neurons were evaluated.
METHODS: the neurotracer FluoroGold was applied to the surfaces of L4/5 discs to label their innervating DRG neurons (n = 30). Of 30 rats, 10 were in a nonpunctured disc sham surgery control group, whereas the other 20 were in experimental groups in which intervertebral discs were punctured with a 23-gauge needle. Etanercept or saline was applied into the punctured discs (n = 10 each treatment). After 14 days of surgery, DRGs from L1 to L6 were harvested, sectioned, and immunostained for CGRP. The proportion of FluoroGold-labeled CGRP-immunoreactive DRG neurons was evaluated in all groups.
RESULTS: FluoroGold-labeled neurons innervating the L4/5 disc were distributed throughout L1-L6 DRGs in all groups. Of the FluoroGold-labeled neurons, the proportion of CGRP-immunoreactive neurons was 21% ± 4% in the sham surgery control group, 32% ± 7% in the puncture + saline group, and 23% ± 4% in the puncture + etanercept group. The proportion of CGRP-immunoreactive neurons was significantly greater in the puncture + saline group compared with the sham control and puncture + etanercept groups (P < 0.01).
CONCLUSION: in this model, CGRP was upregulated in DRG neurons innervating damaged discs. However, direct intradiscal application of etanercept immediately after disc puncture suppressed CGRP expression in DRG neurons innervating injured discs. This finding may further elucidate the mechanism for the effectiveness of etanercept in upregulation of neuropeptide in DRG neurons innervating intervertebral discs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21057386     DOI: 10.1097/BRS.0b013e3181d4be3c

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  10 in total

1.  Anti-RANKL antibodies decrease CGRP expression in dorsal root ganglion neurons innervating injured lumbar intervertebral discs in rats.

Authors:  Masashi Sato; Kazuhide Inage; Yoshihiro Sakuma; Jun Sato; Sumihisa Orita; Kazuyo Yamauchi; Yawara Eguchi; Nobuyasu Ochiai; Kazuki Kuniyoshi; Yasuchika Aoki; Junichi Nakamura; Masayuki Miyagi; Miyako Suzuki; Gou Kubota; Takeshi Sainoh; Kazuki Fujimoto; Yasuhiro Shiga; Koki Abe; Hiroto Kanamoto; Gen Inoue; Kazuhisa Takahashi; Seiji Ohtori
Journal:  Eur Spine J       Date:  2015-06-14       Impact factor: 3.134

Review 2.  Molecular mechanisms of biological aging in intervertebral discs.

Authors:  Nam V Vo; Robert A Hartman; Prashanti R Patil; Makarand V Risbud; Dimitris Kletsas; James C Iatridis; Judith A Hoyland; Christine L Le Maitre; Gwendolyn A Sowa; James D Kang
Journal:  J Orthop Res       Date:  2016-08-12       Impact factor: 3.494

Review 3.  Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration.

Authors:  Yizhong Peng; Xiangcheng Qing; Hongyang Shu; Shuo Tian; Wenbo Yang; Songfeng Chen; Hui Lin; Xiao Lv; Lei Zhao; Xi Chen; Feifei Pu; Donghua Huang; Xu Cao; Zengwu Shao
Journal:  Biomater Transl       Date:  2021-06-28

4.  Dose Optimization for Single Intradiscal Administration of the Tumor Necrosis Factor-α Inhibitor, Etanercept, in Rat Disc Injury Models.

Authors:  Kazuhide Inage; Sumihisa Orita; Kazuyo Yamauchi; Takane Suzuki; Miyako Suzuki; Yoshihiro Sakuma; Go Kubota; Yasuhiro Oikawa; Takeshi Sainoh; Jun Sato; Kazuki Fujimoto; Yasuhiro Shiga; Koki Abe; Hirohito Kanamoto; Masahiro Inoue; Hideyuki Kinoshita; Kazuhisa Takahashi; Seiji Ohtori
Journal:  Asian Spine J       Date:  2016-08-16

Review 5.  Sensory nerve ingrowth, cytokines, and instability of discogenic low back pain: A review.

Authors:  Seiji Ohtori; Masayuki Miyagi; Gen Inoue
Journal:  Spine Surg Relat Res       Date:  2018-01-27

6.  Distinctive roles of tumor necrosis factor receptor type 1 and type 2 in a mouse disc degeneration model.

Authors:  Shanzheng Wang; Guodong Sun; Pan Fan; Lei Huang; Yaofei Chen; Changhong Chen
Journal:  J Orthop Translat       Date:  2021-12-03       Impact factor: 5.191

7.  Dihydroartemisinin Attenuated Intervertebral Disc Degeneration via Inhibiting PI3K/AKT and NF-κB Signaling Pathways.

Authors:  Zhiheng Liao; Deying Su; Hengyu Liu; Caixia Xu; Jinna Wu; Yuyu Chen; Weimin Guo; Shun Zhang; Zhuling Li; Xiaona Ke; Tingting Wang; Taifeng Zhou; Peiqiang Su
Journal:  Oxid Med Cell Longev       Date:  2022-09-09       Impact factor: 7.310

Review 8.  Intervertebral disc therapies for non-specific chronic low back pain: a systematic review and meta-analysis.

Authors:  Camille Daste; Stéphanie Laclau; Margaux Boisson; François Segretin; Antoine Feydy; Marie-Martine Lefèvre-Colau; François Rannou; Christelle Nguyen
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-16       Impact factor: 5.346

Review 9.  Growth factors and anticatabolic substances for prevention and management of intervertebral disc degeneration.

Authors:  Umile Giuseppe Longo; Stefano Petrillo; Edoardo Franceschetti; Nicola Maffulli; Vincenzo Denaro
Journal:  Stem Cells Int       Date:  2011-11-03       Impact factor: 5.443

Review 10.  Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis.

Authors:  Bakri M Assas; Joanne I Pennock; Jaleel A Miyan
Journal:  Front Neurosci       Date:  2014-02-14       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.